Skip to main content

Table 1 Echocardiographic data at pretreatment and 4 Weeks after cell or culture medium transplantation in 3 Groups

From: Stromal Vascular Fraction Transplantation as an Alternative Therapy for Ischemic Heart Failure: Anti-inflammatory Role

 

SVF

BMMNC

Control

Pre treatment

   

LVDd (cm)

0.92 ± 0.02

0.91 ± 0.02

0.92 ± 0.02

LVDs (cm)

0.68 ± 0.03

0.66 ± 0.03

0.68 ± 0.03

FS (%)

26.7 ± 1.6

28.5 ± 2

26.1 ± 2.6

EF (%)

57.0 ± 2.6

59.5 ± 3.1

55.2 ± 3.9

After treatment

   

LVDd (cm)

0.88 ± 0.02*

0.93 ± 0.03*

1.02 ± 0.09

LVDs (cm)

0.60 ± 0.03*

0.65 ± 0.03*

0.78 ± 0.15

FS (%)

31.6 ± 2.6*

30.3 ± 1.7*

23.3 ± 1.1

EF (%)

63.8 ± 3.5*

62.5 ± 2.7*

51.2 ± 1.9

  1. Values are shown as the mean ± SEM. LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; FS, fractional shortening; EF, ejection fraction. * p < 0.05 versus Control group.